|
2025
|
Invention
|
Benzimidazole compound, preparation method therefor, and use thereof. A benzimidazole compound re... |
|
|
Invention
|
Drug for treating pancreatic cancer and use thereof. A drug for treating pancreatic cancer and us... |
|
|
P/S
|
Medicines for human purposes, namely, the medicines for the treatment of lymph cancer, leukemia, ... |
|
2024
|
Invention
|
Drug for treating locally advanced unresectable or metastatic colorectal cancer and use thereof. ... |
|
|
Invention
|
Drug for treating patient with pd-l1 expression positive local advanced or metastatic nsclc and u... |
|
|
Invention
|
Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and chiauranib.
T... |
|
2023
|
Invention
|
Naphthylamide compound, and preparation method therefor and use thereof. A naphthylamide compound... |
|
|
Invention
|
Alkynyl-containing substituted heterocyclic amide derivative, and preparation method therefor and... |
|
|
Invention
|
Biphenyl compound as immunomodulator, preparation method therefor and application thereof.
The p... |
|
|
Invention
|
Hydrazide compound and preparation method therefor and use thereof. Disclosed is a compound havin... |
|
|
Invention
|
Formamide-substituted heterotricyclic derivative, method for preparing same, and use thereof. The... |
|
|
Invention
|
Crystal forms of hydroxamic acid ester compound and salt thereof, and preparation method. The pre... |
|
|
Invention
|
Crystal form of biphenyl compound as immunomodulator and method for preparing same. Disclosed are... |
|
|
Invention
|
Salt form and crystal form of biphenyl compound as immunomodulator and method for preparing same.... |
|
|
Invention
|
Use of chiauranib in resisting pancreatic cancer. The present invention relates to the field of p... |
|
|
Invention
|
Use of chiauranib in combination with anti-metabolism chemotherapeutic drug in treatment of breas... |
|
|
Invention
|
Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and chiauranib. Th... |
|
|
Invention
|
Trka (g667c) and flt3 target inhibitor and combination of same with chidamide. Disclosed is a TRK... |
|
2022
|
Invention
|
Use of ppar agonist in preparation of drug for treating acute myeloid leukemia. The use of a PPAR... |
|
|
Invention
|
Uses of chiauranib and combined administration thereof for treating breast cancer. The present in... |
|
|
Invention
|
Pharmaceutical composition containing protein kinase inhibitor and medical use thereof. Disclosed... |
|
|
Invention
|
Heterocyclic compound and application thereof. Provided is a heterocyclic compound having the str... |
|
|
Invention
|
Pharmaceutical composition containing jak3/jak1/tbk1 selective inhibitor and medical use thereof.... |
|
|
Invention
|
Biphenyl compound as immunomodulator, preparation method therefor and use thereof. A biphenyl com... |
|
|
Invention
|
Class of morpholine derivatives, preparation method therefor and application thereof. A class of ... |
|
2021
|
Invention
|
Hydroxamate compound, preparation method therefor and application thereof.
The present invention... |
|
|
Invention
|
Hydroxamate compound, preparation method therefor and application thereof. The present invention ... |
|
|
Invention
|
Biphenyl compound as immunomodulator, preparation method therefor and application thereof. A biph... |
|
|
Invention
|
Use of chiauranib in combination with immune checkpoint inhibitor in antitumor therapy.
The pres... |
|
|
Invention
|
Use of chiauranib in combination with immune checkpoint inhibitor in antitumor therapy. The prese... |
|
|
Invention
|
Use of chidamide combined with estrogen receptor downregulator in treatment of breast cancer. The... |
|
|
Invention
|
Heterotricyclic compound, preparation method therefor and use thereof. The present invention rela... |
|
|
Invention
|
Use of rbm10 gene. Provided is a biomarker for evaluating the efficacy of Chiauranib or guiding t... |
|
|
Invention
|
Use of chiauranib and drug combination thereof in treatment of non-hodgkin's lymphoma. Provided a... |
|
|
Invention
|
Drug combination for treating diabetes mellitus and complications thereof and pharmaceutical comp... |
|
|
Invention
|
Pharmaceutical composition comprising protein kinase inhibitor and chemotherapeutic drug and use ... |
|
|
Invention
|
Pharmaceutical composition comprising jak3/jak1/tbk1 inhibitor and methotrexate and use thereof. ... |
|
|
Invention
|
Combined pharmaceutical composition for resisting double-hit lymphomas, and use thereof. Disclose... |
|
2020
|
Invention
|
Composition containing aromatic heterocyclic compound in amorphous form, and preparation method t... |
|
|
Invention
|
Use of compound in preventing or treating graft versus host disease.
Use of a compound in preven... |
|
|
Invention
|
Chidamide pharmaceutical composition, preparation method therefor and application thereof.
A chi... |
|
|
Invention
|
Use of kdm5a gene and atrx gene.
The present invention provides use of KDM5A gene and/or ATRX ge... |
|
|
Invention
|
Chiauranib for treatment of small cell lung cancer.
Disclosed are a method for treating small ce... |
|
2019
|
Invention
|
Application of chidamide in combination with r-chop, and drug combination. The present applicatio... |
|
|
Invention
|
Application of chidamide.
The present application relates to the technical field of medicine, an... |
|
|
Invention
|
Quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity.
Provided is a quino... |
|
|
Invention
|
Application of chiglitazar and related compounds thereof.
Provided is an application of chiglita... |
|
|
Invention
|
Combination of histone deacetylase inhibitor and protein kinase inhibitor and pharmaceutical use ... |
